Literature DB >> 31903247

Platelet-to-lymphocyte ratio is an independent prognosticator in patients with esophageal squamous cell carcinoma receiving esophagectomy.

Li-Chun Chen1, Shau-Hsuan Li2, Chien-Ming Lo1, Yen-Hao Chen2, Shun-Chen Huang3, Yu-Ming Wang4, Shang-Yu Chou4, Hung-I Lu1.   

Abstract

BACKGROUND: Systemic inflammation response is a crucial prognostic factor for various cancers. The neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are two inflammation-based prognostic scores. The significance of preoperative NLR and PLR in patients with esophageal squamous cell carcinoma (ESCC) receiving curative esophagectomy remains largely undefined. Hence, this study aimed to evaluate the significance of preoperative NLR and PLR in patients with ESCC receiving curative esophagectomy in southern Taiwan.
METHODS: A consecutive group of 107 patients with ESCC undergoing esophagectomy between January 2001 and December 2012 were retrospectively reviewed. The NLR and PLR of these 107 patients were calculated and correlated with clinicopathological parameters, overall survival (OS), and disease-free survival (DFS).
RESULTS: NLR ≥2.5 was significantly correlated with higher T classification (P=0.006) and advanced clinical AJCC 7th stage (P=0.047). PLR ≥150 was significantly associated with higher T classification (P=0.009). Univariate survival analysis showed that NLR ≥2.5 and PLR ≥150 were associated with poor OS (P=0.009 and P=0.007, respectively) and poor DFS (P=0.006 and P=0.005, respectively). On multivariate comparison, PLR ≥150 was independently associated with poor OS [P=0.001, hazard ratio (HR): 2.475] and poor DFS (P<0.001, HR: 2.509). The 5-year overall and DFS rates were, respectively, 33.3% and 25.0% in patients with PLR ≥150, and 54% and 46% in patients with PLR <150.
CONCLUSIONS: The PLR is an independent prognosticator for patients with ESCC undergoing esophagectomy in southern Taiwan. 2019 Journal of Thoracic Disease. All rights reserved.

Entities:  

Keywords:  Esophageal cancer; esophagectomy; neutrophil-to-lymphocyte ratio (NLR); platelet-to-lymphocyte ratio (PLR); squamous cell carcinoma

Year:  2019        PMID: 31903247      PMCID: PMC6940253          DOI: 10.21037/jtd.2019.11.06

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  21 in total

1.  Which factors are associated with actual 5-year survival of oesophageal squamous cell carcinoma?

Authors:  Jingeng Liu; Xuan Xie; Chao Zhou; Sujiang Peng; Dongping Rao; Jianhua Fu
Journal:  Eur J Cardiothorac Surg       Date:  2011-12-29       Impact factor: 4.191

2.  Phosphorylated p70S6K expression is an independent prognosticator for patients with esophageal squamous cell carcinoma.

Authors:  Shau-Hsuan Li; Chang-Han Chen; Hung-I Lu; Wan-Ting Huang; Wan-Yu Tien; Ya-Chun Lan; Ching-Chang Lee; Yen-Hao Chen; Hsuan-Ying Huang; Alice Y W Chang; Wei-Che Lin
Journal:  Surgery       Date:  2014-11-06       Impact factor: 3.982

3.  Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma.

Authors:  Li-Hui Han; Yi-Bin Jia; Qing-Xu Song; Jian-Bo Wang; Na-Na Wang; Yu-Feng Cheng
Journal:  Asian Pac J Cancer Prev       Date:  2015

4.  Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative resection of oesophageal cancer.

Authors:  Sumanta Dutta; Andrew B C Crumley; Grant M Fullarton; Paul G Horgan; Donald C McMillan
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

5.  A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study.

Authors:  Michael J Proctor; David S Morrison; Dinesh Talwar; Steven M Balmer; Colin D Fletcher; Denis St J O'Reilly; Alan K Foulis; Paul G Horgan; Donald C McMillan
Journal:  Eur J Cancer       Date:  2011-07-01       Impact factor: 9.162

Review 6.  Randomized clinical trials in esophageal carcinoma.

Authors:  Stephen A Barnett; Nabil P Rizk
Journal:  Surg Oncol Clin N Am       Date:  2010-01       Impact factor: 3.495

7.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

8.  Osteopontin Expression Is Associated with the Poor Prognosis in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy.

Authors:  Tai-Jan Chiu; Hung-I Lu; Chang-Han Chen; Wan-Ting Huang; Yu-Ming Wang; Wei-Che Lin; Shau-Hsuan Li
Journal:  Biomed Res Int       Date:  2018-04-30       Impact factor: 3.411

9.  Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma.

Authors:  Ji-Feng Feng; Ying Huang; Qi-Xun Chen
Journal:  World J Surg Oncol       Date:  2014-03-19       Impact factor: 2.754

10.  Prognostic role of platelet to lymphocyte ratio in esophageal cancer: A meta-analysis.

Authors:  Qing-Tao Zhao; Xiao-Peng Zhang; Hua Zhang; Guo-Chen Duan
Journal:  Oncotarget       Date:  2017-11-20
View more
  4 in total

1.  The Platelet-to-Lymphocyte Ratio Is an Independent Prognostic Factor for Patients With Esophageal Cancer Who Receive Curative Treatment.

Authors:  Toru Aoyama; Miwa Ju; Keisuke Komori; Hiroshi Tamagawa; Ayako Tamagawa; Atsushi Onodera; Junya Morita; Itaru Hashimoto; Tetsushi Ishiguro; Kazuya Endo; Haruhiko Cho; Shizuνe Onuma; Momoko Fukuda; Takashi Oshima; Norio Yukawa; Yasushi Rino
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

2.  Platelet-to-lymphocyte ratio is an independent predictor of chemoradiotherapy-related esophageal fistula in esophageal cancer patients.

Authors:  Dong Han; Jiajia Zhang; Jingjing Zhao; Tongda Lei; Xi Chen; Tian Zhang; Hui Wei; Yong Guan; Jing Wang; Wencheng Zhang; Lujun Zhao; Jun Wang; Zhiyong Yuan; Yongchun Song; Ningbo Liu; Qingsong Pang; Ping Wang
Journal:  Ann Transl Med       Date:  2020-09

3.  A Novel Systemic Inflammatory Score Combined With Immunoinflammatory Markers Accurately Reflects Prognosis in Patients With Esophageal Cancer.

Authors:  Takafumi Suzuki; Yusuke Ishibashi; Hironori Tsujimoto; Shinsuke Nomura; Keita Kouzu; Yujiro Itazaki; Takao Sugihara; Manabu Harada; Nozomi Ito; Hidekazu Sugasawa; Yoji Kishi; Hideki Ueno
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

4.  Neutrophil Lymphocyte Ratio to Albumin Ratio and White Blood Cell to Hemoglobin Ratio as Prognostic Markers for Hepatocellular Carcinoma Patients Who Underwent Curative Hepatectomy.

Authors:  Xueqin Shen; Wei Wang; Xiaoping Niu
Journal:  Int J Gen Med       Date:  2021-08-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.